Published in Hepatology on August 01, 2003
Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target. Int J Biol Sci (2011) 1.70
STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia. PLoS One (2011) 1.61
JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia. Am J Physiol Endocrinol Metab (2012) 1.56
IL-22 is involved in liver regeneration after hepatectomy. Am J Physiol Gastrointest Liver Physiol (2009) 1.24
Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice. J Transl Med (2013) 1.14
Interleukin-6 mediates G(0)/G(1) growth arrest in hepatocellular carcinoma through a STAT 3-dependent pathway. J Surg Res (2007) 1.03
Inflammation, organomegaly, and muscle wasting despite hyperphagia in a mouse model of burn cachexia. J Cachexia Sarcopenia Muscle (2012) 0.97
Chronic ethanol consumption modulates growth factor release, mucosal cytokine production, and microRNA expression in nonhuman primates. Alcohol Clin Exp Res (2013) 0.95
BMP4 is a novel paracrine inhibitor of liver regeneration. Am J Physiol Gastrointest Liver Physiol (2012) 0.95
Carbon monoxide enhances early liver regeneration in mice after hepatectomy. Hepatology (2011) 0.94
Toll-like receptor 4 and myeloid differentiation factor 88 provide mechanistic insights into the cause and effects of interleukin-6 activation in mouse liver regeneration. Hepatology (2011) 0.94
Tob1 is a constitutively expressed repressor of liver regeneration. J Exp Med (2010) 0.92
Stem cell factor and its receptor, c-kit, are important for hepatocyte proliferation in wild-type and tumor necrosis factor receptor-1 knockout mice after 70% hepatectomy. Surgery (2008) 0.88
Inflammation-induced acute phase response in skeletal muscle and critical illness myopathy. PLoS One (2014) 0.85
Liver inflammation and metabolic signaling in ApcMin/+ mice: the role of cachexia progression. PLoS One (2015) 0.82
STAT3 in the systemic inflammation of cancer cachexia. Semin Cell Dev Biol (2016) 0.82
Increased DNA binding activity of NF-kappaB, STAT-3, SMAD3 and AP-1 in acutely damaged liver. World J Gastroenterol (2006) 0.81
Mouse CD11b+Kupffer Cells Recruited from Bone Marrow Accelerate Liver Regeneration after Partial Hepatectomy. PLoS One (2015) 0.80
The E3 ubiquitin ligase TRIM62 and inflammation-induced skeletal muscle atrophy. Crit Care (2014) 0.79
Specific activin receptor-like kinase 3 inhibitors enhance liver regeneration. J Pharmacol Exp Ther (2014) 0.79
Blockade of the apelin-APJ system promotes mouse liver regeneration by activating Kupffer cells after partial hepatectomy. J Gastroenterol (2014) 0.78
Estrogen suppresses heptatic IκB expression during short-term alcohol exposure. Inflamm Res (2012) 0.78
Role of ischaemic preconditioning in liver regeneration following major liver resection and transplantation. World J Gastroenterol (2007) 0.77
Interleukin-22 contributes to liver regeneration in mice with concanavalin A-induced hepatitis after hepatectomy. World J Gastroenterol (2016) 0.75
Ischaemic Preconditioning and Intermittent Clamping Does not Influence Mediators of Liver Regeneration in a Human Liver Sinusoidal Endothelial Cell Model of Ischaemia-Reperfusion Injury. Gastroenterology Res (2012) 0.75
Alcohol Disrupts Human Liver Stem/Progenitor Cell Proliferation and Differentiation. J Stem Cell Res Ther (2014) 0.75
Effects of tacrolimus and insulin in a liver regeneration model in growing animals with portal vein stenosis: immunohistochemical and molecular studies. Pediatr Surg Int (2014) 0.75
Induction of cachexia in mice by systemically administered myostatin. Science (2002) 4.39
IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8- entheseal resident T cells. Nat Med (2012) 4.38
The influence of Hispanic ethnicity on nonsmall cell lung cancer histology and patient survival: an analysis of the Survival, Epidemiology, and End Results database. Cancer (2012) 3.12
Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J Exp Med (2009) 2.82
Cancer care in the pediatric surgical patient: a paradigm to abolish volume-outcome disparities in surgery. Surgery (2008) 2.81
Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem (2003) 2.67
Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis. Hepatology (2012) 2.61
Inflammatory myofibroblastic tumors. J Surg Oncol (2006) 2.56
Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes (2003) 2.40
Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages. Blood (2007) 2.37
The collagen binding alpha1beta1 integrin VLA-1 regulates CD8 T cell-mediated immune protection against heterologous influenza infection. Immunity (2004) 2.13
Kupffer cell-dependent hepatitis occurs during influenza infection. Am J Pathol (2006) 1.98
Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors. J Am Coll Surg (2006) 1.90
Outcomes for soft-tissue sarcoma in 8249 cases from a large state cancer registry. J Surg Res (2007) 1.82
Liver regeneration. J Am Coll Surg (2003) 1.79
Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation. J Virol (2007) 1.75
Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis. Alcohol Clin Exp Res (2011) 1.72
Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database. J Bone Joint Surg Am (2009) 1.71
Lethal injection for execution: chemical asphyxiation? PLoS Med (2007) 1.63
STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia. PLoS One (2011) 1.61
Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients. J Surg Res (2009) 1.61
Impact of teaching facility status and high-volume centers on outcomes for lung cancer resection: an examination of 13,469 surgical patients. Ann Surg Oncol (2008) 1.60
Glutamate cysteine ligase modifier subunit deficiency and gender as determinants of acetaminophen-induced hepatotoxicity in mice. Toxicol Sci (2007) 1.60
African American and poor patients have a dramatically worse prognosis for head and neck cancer: an examination of 20,915 patients. Cancer (2008) 1.57
Disparities in survival among women with invasive cervical cancer: a problem of access to care. Cancer (2009) 1.56
JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia. Am J Physiol Endocrinol Metab (2012) 1.56
Retroperitoneal and truncal sarcomas: prognosis depends upon type not location. Ann Surg Oncol (2007) 1.55
Defining the role of surgery for primary gastrointestinal tract melanoma. J Gastrointest Surg (2007) 1.55
Defining treatment and outcomes of hepaticojejunostomy failure following pancreaticoduodenectomy. J Gastrointest Surg (2013) 1.51
Does surgery or radiation therapy impact survival for patients with extrapulmonary small cell cancers? J Surg Oncol (2011) 1.50
Are many community hospitals undertreating breast cancer?: lessons from 24,834 patients. Ann Surg (2008) 1.50
Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair. Hepatology (2006) 1.49
Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients. Ann Surg (2007) 1.48
Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia. Biochem Biophys Res Commun (2009) 1.45
Does chemoradiotherapy improve outcomes for surgically resected adenocarcinoma of the stomach or esophagus? Ann Surg Oncol (2009) 1.44
IL-33 induces IL-13-dependent cutaneous fibrosis. J Immunol (2009) 1.42
The ABC transporter AtABCB14 is a malate importer and modulates stomatal response to CO2. Nat Cell Biol (2008) 1.42
Primary lymphoma of bone in adult patients. Cancer (2010) 1.41
Pediatric intestinal foregut and small bowel solid tumors: a review of 105 cases. J Surg Res (2009) 1.40
The Drivers of Academic Success in Cleft and Craniofacial Centers: A 10-Year Analysis of over 2000 Publications. Plast Reconstr Surg (2017) 1.40
Perceptions of student-observers in the operating room. J Surg Res (2011) 1.39
Survival effects of adjuvant chemoradiotherapy after resection for pancreatic carcinoma. Arch Surg (2010) 1.39
Ewing sarcoma demonstrates racial disparities in incidence-related and sex-related differences in outcome: an analysis of 1631 cases from the SEER database, 1973-2005. Cancer (2009) 1.38
TLR-dependent cross talk between human Kupffer cells and NK cells. J Exp Med (2008) 1.37
Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury. Shock (2005) 1.31
Local intrahepatic CD8+ T cell activation by a non-self-antigen results in full functional differentiation. J Immunol (2006) 1.29
Do racial or socioeconomic disparities exist in lung cancer treatment? Cancer (2010) 1.25
Leukemia inhibitory factor inhibits neuronal terminal differentiation through STAT3 activation. Proc Natl Acad Sci U S A (2002) 1.23
Interleukin-6 inhibits cell proliferation in a rat model of hepatocellular carcinoma. Liver Int (2005) 1.23
Malignant pancreatic tumors: incidence and outcome in 58 pediatric patients. J Pediatr Surg (2009) 1.21
Interleukin-6 inhibits oxidative injury and necrosis after extreme liver resection. Hepatology (2007) 1.20
Decreased aquaporin expression leads to increased resistance to apoptosis in hepatocellular carcinoma. Cancer Lett (2006) 1.19
Interleukin-6 is an important in vivo inhibitor of intestinal epithelial cell death in mice. Gut (2008) 1.16
Detecting blunt pancreatic injuries. J Gastrointest Surg (2002) 1.16
Molecular pathogenesis of hepatocellular carcinoma. J Surg Res (2006) 1.15
Outcomes of malignant CNS ependymomas: an examination of 2408 cases through the Surveillance, Epidemiology, and End Results (SEER) database (1973-2005). J Surg Res (2009) 1.14
Polyketal copolymers: a new acid-sensitive delivery vehicle for treating acute inflammatory diseases. Bioconjug Chem (2008) 1.14
Rhabdomyosarcoma in children: a SEER population based study. J Surg Res (2011) 1.13
Rodent models of alcoholic liver disease: of mice and men. Alcohol (2012) 1.11
Hepatitis C virus core protein subverts the antiviral activities of human Kupffer cells. Gastroenterology (2009) 1.11
Results of 23,810 cases of ductal carcinoma-in-situ. Ann Surg Oncol (2007) 1.10
5'-Triphosphate-RNA-independent activation of RIG-I via RNA aptamer with enhanced antiviral activity. Nucleic Acids Res (2011) 1.09
Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling. Biochim Biophys Acta (2009) 1.09
Malignant abdominal mesothelioma: defining the role of surgery. J Surg Oncol (2009) 1.09
The roles of neoadjuvant radiotherapy and lymphadenectomy in the treatment of esophageal adenocarcinoma. Ann Surg Oncol (2009) 1.09
IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass. J Immunol (2011) 1.08
Collagen-elastin ratio predicts burst pressure of arterial seals created using a bipolar vessel sealing device in a porcine model. Surg Endosc (2011) 1.07
Body surface area prediction in normal, hypermuscular, and obese mice. J Surg Res (2008) 1.07
S-adenosyl-L-methionine attenuates oxidative stress and hepatic stellate cell activation in an ethanol-LPS-induced fibrotic rat model. Shock (2008) 1.07
AKT1 provides an essential survival signal required for differentiation and stratification of primary human keratinocytes. J Biol Chem (2006) 1.06
Pediatric non-Wilms renal tumors: subtypes, survival, and prognostic indicators. J Surg Res (2010) 1.06
Obesity and weight loss at presentation of lung cancer are associated with opposite effects on survival. J Surg Res (2011) 1.06
Glutamate-cysteine ligase attenuates TNF-induced mitochondrial injury and apoptosis. Free Radic Biol Med (2004) 1.05
Plunc, a member of the secretory gland protein family, is up-regulated in nasal respiratory epithelium after olfactory bulbectomy. J Biol Chem (2002) 1.05
Caspase-3-Dependent Cleavage of the Glutamate-L-Cysteine Ligase Catalytic Subunit during Apoptotic Cell Death. Am J Pathol (2002) 1.04
Hepatectomy enables prolonged survival in select patients with isolated noncolorectal liver metastasis. J Am Coll Surg (2006) 1.04
Osteosarcoma: improvement in survival limited to high-grade patients only. J Cancer Res Clin Oncol (2010) 1.03
Interleukin-6 mediates G(0)/G(1) growth arrest in hepatocellular carcinoma through a STAT 3-dependent pathway. J Surg Res (2007) 1.03
What is the institutional financial impact of an MD-PhD program without extramural funding? Teach Learn Med (2010) 1.03
Solid polymeric microparticles enhance the delivery of siRNA to macrophages in vivo. Nucleic Acids Res (2009) 1.02
Acetaminophen-induced liver injury is attenuated in male glutamate-cysteine ligase transgenic mice. J Biol Chem (2006) 1.02
Activation of MDL-1 (CLEC5A) on immature myeloid cells triggers lethal shock in mice. J Clin Invest (2011) 1.01
Cryoablation of unresectable pancreatic cancer. Surgery (2002) 1.01
Thrombophilic state in cancer, part I: biology, incidence, and risk factors. J Surg Oncol (2011) 1.01
Scientific impact of women in academic surgery. J Surg Res (2008) 1.00
Effect of in vivo loss of GDF-15 on hepatocellular carcinogenesis. J Cancer Res Clin Oncol (2008) 1.00
Markedly improving survival of neuroblastoma: a 30-year analysis of 1,646 patients. Pediatr Surg Int (2007) 0.99
Surgery does not adversely affect survival in primary gastrointestinal lymphoma. J Surg Oncol (2009) 0.99
Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma. Hepatology (2002) 0.99
Pediatric solid tumors and second malignancies: characteristics and survival outcomes. J Surg Res (2009) 0.98
Inhibition of hepatitis C virus replication by IFN-mediated ISGylation of HCV-NS5A. J Immunol (2010) 0.98